The A to I editing landscape in melanoma and its relation to clinical outcome

The A to I editing landscape in melanoma and its relation to clinical outcome

RNA editing refers to non-transient RNA modifications that occur after transcription and prior to translation by the ribosomes. RNA editing is more widespread in cancer cells than in non-transformed cells and is associated with tumorigenesis of various cancer tissues. However, RNA editing can also g...

Full description

Bibliographic Details
Main Authors: Austeja Amweg, Marina Tusup, Phil Cheng, Ernesto Picardi, Reinhard Dummer, Mitchell P Levesque, Lars E French, Emmanuella Guenova, Severin Läuchli, Thomas Kundig, Mark Mellett, Steve Pascolo
Format: Article
Language:English
Published: Taylor & Francis Group 2022-12-01
Series:RNA Biology
Subjects:
adar
a-to-i editing
alu sequences
editing
melanoma
immune checkpoint inhibitors
immunotherapy
Online Access:http://dx.doi.org/10.1080/15476286.2022.2110390

Internet

http://dx.doi.org/10.1080/15476286.2022.2110390

Similar Items